Skip to main content
An official website of the United States government

Funded Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Elenitoba-Johnson, Kojo S. J.

Sloan-Kettering Inst Can Research
United States

Genomic biomarkers of splenic lymphoma 5R01CA255655-06
Elias, Kevin

Cleveland Clinic Lerner Com-Cwru
United States

Ovarian cancer risk stratification using circulating miRNAs to assess BRCAness 7R03CA283252-02 Christos Patriotis, Ph.D., M.Sc.
Ellerton, John A

Southern Nevada Cancer Research Fdn
United States

NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Required) 3UG1CA189829-11S1 Vanessa A. White, M.P.H.
Elmore, Joann G

University Of California Los Angeles
United States

Optimizing the Human-Computer Interaction in Pathology: Understanding the Impact of Computer-Aided Diagnosis Tools on Pathologists' Interpretive Performance 1R01CA288824-01A1 Claire Zhu, Ph.D.
Elswick, Ronald K

Virginia Commonwealth University
United States

A Randomized Controlled Trial using a Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults with Cancer 5R01CA286799-03 Asad Umar, D.V.M., Ph.D.
Esserman, Laura J

University Of California, San Francisco
United States

RISE UP for Breast Cancer 1R13CA294950-01 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Esserman, Laura J

University Of California, San Francisco
United States

WISDOM: A platform to optimize subtype-specific screening and prevention 1P01CA281826-01A1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Esserman, Laura J

University Of California, San Francisco
United States

Extending the Diversity, Reach, and Generalizability of the WISDOM Study 5R01CA237533-05 Claire Zhu, Ph.D.
Fabian, Carol J.

University Of Kansas Medical Center
United States

Biomarker-Based Phase IIB Trial of (Bazedoxifene-Conjugated Estrogen) to Reduce Risk for Breast Cancer 5R01CA249437-05 Edward Sauter, M.D., Ph.D.
Fahrmann, Johannes F

University Of Tx Md Anderson Can Ctr
United States

Blood-Based Biomarkers for Personalized Risk Assessment of Breast and Ovarian Cancer 5U01CA282216-02 Claire Zhu, Ph.D.